System design
The co-design workshops focused on options for integrating mHealth as a supportive tool for diabetes care – designing a system for sharing patient-gathered mHealth data during consultations. Common design features that were identified included a) the presentation of PGD in a summary on the first screen of the system, with the option to select more detailed views and combinations of information on subsequent screens, b) graphs and charts were popular choices for visual representations, especially when comparing different data types, c) visual indications of change such as arrows or symbols related to each data type based on desired and undesired clinical values, e.g. blood glucose values in high (yellow), acceptable (green) or low (red) ranges, d) presentations of data that is relevant to the patient and e) efficient to use. While both those with T1D and T2D believed that sharing data remotely or before the consultation would allow them to receive answers and guidance during challenging situations and save time for both patients and providers, most providers were sceptical of this idea noting that patients must be present during the discussion in order to share and explain their data effectively. With these design features, both parties would be able to choose which data to look at, and then agree upon feasible solutions together.
These design features support the concept of “shared-decision making”. While this term was meant to refer to patients and providers discussing and sharing the responsibility of deciding the best course of action for both self-management and medical treatment options together [20], much of the literature refers to HCPs making the final decisions in a “paternalistic model” [31, 32], have cited the challenges of or referenced the lack of specific suggestions for how to achieve this ideal [33, 34]. Even when shared-decision making is used in its truest intended way, it still faces challenges such as patients’ lack of understanding of their disease and the providers’ unwavering focus on clinical measures [33]. The results of these workshops suggest that patients and HCPs see that potential collaborative point between their areas of expertise – providers’ medical knowledge and the patients’ mHealth self-management experience an PGD– can lead to true shared-decision making and, subsequently, feasible health goals for individuals.
Collaboration and understanding
The shared aim amongst patient and healthcare provider participants of displaying these data was to facilitate discussion and shared decision-making. Patients and providers independently and consistently described the value of discussions, exchanging valuable and useful information and for improved communication, not just about the data itself but about expectations and intentions. For example, both those with T1D and T2D wanted to know which data healthcare providers were interested in or needed in order to provide specific feedback and recommendations. While patients hoped that providers could relate to and interpret PGD, providers were quick to explain that it is an unrealistic expectation because the healthcare system does not provide resources to teach providers about how to discuss the various mHealth technologies in care practice.
Participants also expressed an understanding of their counterparts’ situations within diabetes care in general. For example, those with T2D understood that GPs may not be the only, or even the most knowledgeable, source of answers for their diabetes-specific questions. This was expressed with empathy, not judgement. Instead it prompted discussion about realistic alternatives such as going to visit hospital nurses or reputable internet sites. Specialists were particularly concerned with understanding the unique situations of their individual patients. While in some cases their comments were not directly related to the question being asked, it forced us to take a step back in the discussion and understand the reality of diabetes care. For example those with T1D, where one specialist urged us to keep in mind that treatment is about the individual person and their specific situation - a concept which should be more prominently addressed in our mHealth research; addressing those with T1D as a group is not actionable given the unique needs of each person. The other specialist emphasized that providers need a comprehensive understanding to effectively guide an individual, i.e. understanding their mental state, resources and intentions in order to generate a realistic goal for their diabetes. A participant with T1D also reinforced this from the patient perspective by explaining that they would rather have a conversation with their HCP about which data to share in relation to a certain situation so that the consultation could be more productive and targeted.
It is also important to note that the participating individuals with T1D portrayed the need for data-sharing as very straight forward – seeing the situation from the perspective of someone who already is familiar with, and uses, medical and mHealth technologies; i.e. they present their data and the healthcare provider can identify patterns. However, participating specialists made it clear that their perceptions and expectations of sharing data during consultations is much more complex. While some patients can come with a well-prepared agenda, providers also have to prepare to relate to those who only use paper diaries as well as those who try, but do not manage to use the technology as specialists would hope.
Data sharing and Information exchange
Specialists were very aware of the impact of accurate and complete data sets because collecting data is useless if the user is unable to determine meaning from what they measure. They expressed several times that each decision about a patient’s case not only had to be informed by their sense of the individual’s personal situation, e.g. other responsibilities in their life and wellbeing, but also the accuracy of the representations of their diabetes health, e.g. blood glucose levels in relation to insulin doses. GPs, however, were not as concerned with where the data came from as expected. While they did emphasize that the data was representative of the patient’s situation, because, as some explained, they did not intend to alter medication or clinical treatment plans based on this data, the exchange of information was more important. Instead they believed that they could use PGD as an indicator for the patient’s progress and a basis for which patients and providers could together develop self-management recommendations.
A significant distinction between the meaning of “data” and “information” emerged from these discussions. Data is useless on its own. Individuals need to have a purpose, intention and questions in order to direct what data to collect as well as how much and what information, evident from the whole collection of data types, can be identified and presented to their healthcare provider. Healthcare providers may be interested in specific data points when “something special is going on”. However, again, participating providers believed that individual data points, or even a collection of one data type, are useless without context.
Issues that data-sharing can and cannot solve
By comparing participants’ backgrounds, i.e. general self-management and clinical practice experiences and needs, and their ideas about sharing PGD through a dedicated system we were able to generate a better understanding of what they believe can and cannot be addressed, let alone solved, with sharing data from mHealth devices. While the primary aim was to gather input about the design and functionalities a system should have, participants provided additional information about issues surrounding the use of the system. Especially those with T2D expressed that they often did not know why their blood glucose values were changing so drastically. This was an example of a solvable issue because their ideal solution was that a data-sharing system could not only identify a patient’s challenge areas but correlate the concerning blood glucose values, for example, with their food and medication. Issues that needed to be addressed before such a system could even be realistically implemented were mHealth technology training and support for healthcare providers. Both specialists and GPs expressed their limited knowledge and frustration with not having the resources they need to become aware of or optimize use of mHealth and PGD during clinical practice. For example, specialists repeatedly emphasized their concern about resource management, when technologies required nurses to provide more time and support for a small group of CGM users, and technology training in general, because there are too many different types of technologies to familiarize themselves with.
Proposed data-sharing system vs. state-of-the-art
We aimed to address what it would take to make the collaboration between patients and healthcare providers using PGD possible and useful for all users. Some of the unique design ideas and purposes for the system that resulted from these discussions were the overwhelming agreement that the system should generate discussions, and more importantly, shared decision-making. The system should be flexible and present an overview of patient-relevant data, and give the patient-provider team the option of further exploring certain data at their discretion. These options and intentions differ from many commercial options or other tested interventions available at the time. Typically, the responsibility and ability to interpret the data and make decisions is one-sided - either skewed toward patient self-management, such as apps found on app stores, or clinical monitoring and oversight of only one parameter such as CGMs [35]. For example, an individual with T1D can use an app to track how each type of food affected their BG levels to meet their goals, whereas an HCP may prefer to see summaries of data such as medication use and response, which can then be compared to lab results. However, participants of these workshops agreed that the potential benefit of using a data-sharing system that would allow both parties to explore the data together, would be to foster mutual understanding and discussion of the data, which could lead to feasible recommendations. The presented users’ feedback support the notion that patients and providers working separately, e.g. with separate agendas for the consultation and poor communication, is not as effective as identifying common needs of both parties and designing systems to support those.
Reflections on the research method
With respect to the research method itself, it is important to note that these presented results highlighted a significant difference, and challenge, of mHealth research compared to traditional research. Traditional research on medical tools and services follows a thorough, focused and lengthy process. Spending much time on these interventions options is expected and healthcare providers, thanks to the validated and trusted methods of inquiry, accept the results. However, research on mHealth tools and services requires a more user-involved, comprehensive and rapid approach. It calls for not only validation of the technology – which still lacks a standard process, but at the same time, the validation of feasible options for integration into medical system workflows. Therefore, we as researchers must re-evaluate how best to perform research that answers traditional questions, e.g. hard health outcomes, as well as those that are unique to mHealth and personal health alternatives, e.g. ways of gathering and displaying data that both healthcare providers and patient, as experts in their own health, can understand. This includes taking advantage of new resources, e.g. expert patients in mHealth and social media, and more actively collaborating with healthcare authorities and organizations to determine feasible health service options to support mHealth integration for both patients and practitioners. Many co-design workshops do involve patients and HCPs. However, they do so most commonly in separate sessions [36]. In research practice, the interpretation of the resulting participant feedback, often would have to be inferred rather than explicitly stated. In other words, there is usually limited or no possibility for participants in different groups to correct one another’s assumptions. We hope that by demonstrating how patients and HCPs can discuss solutions together, we can encourage others to use the EBCD method more in the mHealth and personal health field.
Lessons learned
With regard to the methods and approaches used to conduct these co-design workshops, we have generated a list of “lessons learned” (Table 11). Planning of the workshop sessions and activities were generated iteratively over months to ensure that all participants felt prepared and safe to share their perspectives and that we as a research team would receive the feedback necessary to design an end-user-based system for sharing data. We experienced the need for a research team to be flexible, inclusive and have an open agenda when inviting end-users to participate in directing the research.
Study limitations
Geographical region
Limitations of these workshops resulted largely from the convenience sampling from a specific geographical location – Northern Norway. The relevance of this is that the typical culture of the medical system is less hierarchical. This can sometimes extend to the relationship between patients and their healthcare providers. The consequence is that the use of a joint session in the co-design workshops and gathered feedback therein may not be representative of the type of feedback, e.g. the unabashed correction of assumptions, that could be gathered in other cultures or geographical regions.
Gender balance
Another limitation was the lack of gender balance amongst our participants. The relevance of this is that, in general, there are differences between genders with and without the use of technologies. These differences stem from their daily responsibilities and cultural roles that research should be addressing and that impact the outcomes and application of scientific findings in healthcare practice [37]. While we aimed to recruit equal numbers of each gender, few female or non-gender-binary participants expressed interest in participating, e.g. during the T2D patient session in which there were only men. The consequences of this are that there was an overrepresentation of suggestions about how technology should function that suit men, e.g. the ability to collect and share types of data that may be more or less important to other genders. To ensure more balanced participation in future studies, we could allow for a longer response time during the recruitment process, and/or advertise the study in different media.
Participants’ level of technology experience
The convenience sampling also relied on recruiting patients who used the in-house developed Diabetes Diary app and were therefore already engaged in mHealth for diabetes. The relevance of convenience sampling for mHealth studies is to recruit those who have experience and therefore experience-based suggestions for how to address the call for mHealth integration into clinical practices; such a group would be likely to consider sharing their app data with their HCPs and would be more likely to know what they would want from a system designed to do so. However, we do acknowledge that these participants were not representative of all patients with diabetes. As the specialist participants echoed, they only meet a small percentage of patients who use medical devices and mHealth technologies. The consequence of this is the potential to widen the digital divide by focusing on further development of modern technologies instead of focusing on how existing technologies can be more inclusively developed and supplied. In the future, all interested and eligible (18 years +) parties could be included to ensure that feedback about mHealth represents not only additional and advanced functionalities but also improvements on existing functionalities to lower the barrier-of-use and increase the benefits of personal technologies for diabetes self-management.
Focus of the discussion guides
Further, discussion guide questions focused on data-sharing, use of mHealth and healthcare consultations, not on the demographics of the participants. This led to an incomplete data set, i.e. lack of information about duration of diabetes, exact age, HbA1c, education and other potentially relevant factors. While the primary focus of these workshops was to explore the impact of participants’ experiences and preferences on the design and potential use of a data-sharing system, the consequence was a lack of consideration for what younger vs. older individuals would need from such a system or how they would experience sharing their data with healthcare providers. This can be overcome in future studies, without affecting the workshop time, by the simple addition of a demographic survey at the beginning or prior to the workshop start, perhaps as a part of the informed consent process.